Scott Potter

MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes

Mark D. Erion, Paul D. van Poelje, Qun Dang et al. · Proceedings of the National Academy of Sciences · 2005 · 162 citations · Full text

Human Fbpase, Aldo-keto Reductase, Chemical Biology +20

Discovery of a Series of Phosphonic Acid-Containing Thiazoles and Orally Bioavailable Diamide Prodrugs That Lower Glucose in Diabetic Animals Through Inhibition of Fructose-1,6-Bisphosphatase

Qun Dang, Yan Liu, Daniel K. Cashion et al. · Journal of Medicinal Chemistry · 2010 · 158 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +14

Discovery of Potent and Specific Fructose-1,6-Bisphosphatase Inhibitors and a Series of Orally-Bioavailable Phosphoramidase-Sensitive Prodrugs for the Treatment of Type 2 Diabetes

Qun Dang, Srinivas Rao Kasibhatla, K. Raja Reddy et al. · Journal of the American Chemical Society · 2007 · 95 citations

Pharmaceutical Science, Glycobiology, Glucose Production +17

Inhibition of Fructose 1,6-Bisphosphatase Reduces Excessive Endogenous Glucose Production and Attenuates Hyperglycemia in Zucker Diabetic Fatty Rats

Paul D. van Poelje, Scott Potter, Visvanathan Chandramouli et al. · Diabetes · 2006 · 86 citations

Fbpase Inhibitors, Attenuates Hyperglycemia, Insulin Signaling +18

Fructose-1,6-bisphosphatase Inhibitors. 2. Design, Synthesis, and Structure−Activity Relationship of a Series of Phosphonic Acid Containing Benzimidazoles that Function as 5′-Adenosinemonophosphate (AMP) Mimics

Qun Dang, Srinivas Rao Kasibhatla, Wei Xiao et al. · Journal of Medicinal Chemistry · 2009 · 67 citations · Full text

Fbpase Inhibitors, Chemical Biology, Pharmaceutical Chemistry +18